Cargando…
CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer
The development of chemoresistance reduces the efficacy of anti‐cancer drugs. Cervical cancer is still one of the most common cancer types in developing countries. The oncogenic protein high mobility group AT‐hook 2 (HMGA2) is involved in the development and progression of tumors, although its role...
Autores principales: | Shi, Zhan, Wu, Ding, Xu, Hao, Yang, Ju, Sun, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329774/ https://www.ncbi.nlm.nih.gov/pubmed/34115920 http://dx.doi.org/10.1002/2211-5463.13228 |
Ejemplares similares
-
CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression
por: Yang, Bing, et al.
Publicado: (2023) -
CSNK2 in cancer: pathophysiology and translational applications
por: Strum, Scott W., et al.
Publicado: (2021) -
Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases
por: Unni, Prasida, et al.
Publicado: (2022) -
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
por: Wang, Chunyan, et al.
Publicado: (2021) -
Targeting Csnk1a1 in leukemia
por: Stegmaier, Kimberly
Publicado: (2014)